Has Natasha Tiffany, MD received payments from drug or device companies?

Yes. Drug and device makers reported $41,066 in general payments to Natasha Tiffany, MD across 147 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Natasha Tiffany, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Natasha Tiffany, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Natasha Tiffany, MD

Hematology & Oncology · Bend, ORNPI 1972697167

Payments from drug & device makers

$41,066in general payments, 2019–2025

Across 147 payments — averaging $279.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Daiichi Sankyo Inc.$24K
Incyte Corporation$13K
Heron Therapeutics, Inc.$1K
Johnson & Johnson$281
Astellas Pharma US Inc$277
Novartis$223
plus $2K from 38 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Daiichi Sankyo Inc.	7	$23,600
Incyte Corporation	14	$13,050
Heron Therapeutics, Inc.	1	$1,300
Johnson & Johnson	11	$281
Astellas Pharma US Inc	8	$277
Novartis	10	$223
Merck	9	$203
E.r. Squibb & Sons, L.L.C.	7	$170
AstraZeneca(2 entities)	7	$136
Pfizer	7	$127
Springworks Therapeutics, Inc.	1	$125
AVEO Pharmaceuticals, Inc.	7	$119
Sanofi	4	$114
Sanofi-aventis U.S. LLC	1	$100
Adaptive Biotechnologies Corporation	1	$97
Pharmacyclics LLC, An Abbvie Company	2	$97
Janssen Scientific Affairs, LLC	1	$84
GSK	4	$82
Gilead(2 entities)	4	$72
Eisai Inc.	3	$60
Genentech USA, Inc.	4	$57
Puma Biotechnology, Inc.	3	$56
Amgen	2	$49
Bristol Myers Squibb	2	$49
Rigel Pharmaceuticals, Inc.	2	$47
Regeneron Healthcare Solutions, Inc.	2	$44
EMD Serono, Inc.	2	$43
AbbVie	2	$42
Takeda Pharmaceuticals U.S.A., Inc.	2	$35
Acrotech Biopharma Inc.	2	$34
Ipsen Biopharmaceuticals, Inc	2	$32
Apellis Pharmaceuticals, Inc.	1	$27
Pharmacosmos Therapeutics Inc.	1	$27
Mirati Therapeutics, Inc.	1	$26
Organon	1	$22
Verity Pharmaceuticals Inc.	1	$21
Foundation Medicine, Inc.	1	$20
Servier Pharmaceuticals LLC	1	$19
Agios Pharmaceuticals, Inc.	1	$19
Tesaro, Inc.	1	$19
Exelixis Inc.	1	$17
Blueprint Medicines Corporation	1	$16
Seagen Inc.	1	$16
Aurobindo Pharma USA, Inc.	1	$13

How this compares

$41,066 in reported general payments places this provider in the 60th percentile of 112 hematology & oncology providers in Oregon.

See all hematology & oncology providers in Oregon →

Medicare billing

Part B allowed, 2024

$3,262,014

Medicare patients

626

Services billed

136,970

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Bend

Christina FitzmauriceBend$199K
Pradip RustagiBend$98K
Andrew ChenBend$81K
Brian EricksonBend$50K
William SchmidtBend$27K
Michael HeinrichPortland$25M
Jay AndersenPortland$8.3M
Elie TraerPortland$6.5M
Ian SchnadigTualatin$6.4M
Jacqueline VukyPortland$5.4M

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →